# Comparison of Vaginal PGE2 (Dinoprostone) and Vaginal Misoprostol for Induction of Labour in Primigravid Term Pregnancy

> **NCT07559812** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Mayo Hospital Lahore** · enrollment: 240 (actual)

## Conditions studied

- Labor, Induced
- Term Pregnancy
- Cervical Ripening

## Interventions

- **DRUG:** Misoprostol
- **DRUG:** Dinoprostone 3 mg

## Key facts

- **NCT ID:** NCT07559812
- **Lead sponsor:** Mayo Hospital Lahore
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-10-29
- **Primary completion:** 2026-04-29
- **Final completion:** 2026-04-29
- **Target enrollment:** 240 (ACTUAL)
- **Last updated:** 2026-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07559812

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07559812, "Comparison of Vaginal PGE2 (Dinoprostone) and Vaginal Misoprostol for Induction of Labour in Primigravid Term Pregnancy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07559812. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*